Filing Details

Accession Number:
0001209191-22-008042
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-09 16:39:19
Reporting Period:
2022-02-07
Accepted Time:
2022-02-09 16:39:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1163165 Conocophillips COP Petroleum Refining (2911) 010562944
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1848288 G Heather Sirdashney 16930 Park Row Drive
Houston TX 77084
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-07 11,000 $49.76 11,000 No 4 M Direct
Common Stock Disposition 2022-02-07 11,000 $92.43 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2022-02-07 11,000 $0.00 11,000 $49.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,700 2020-02-14 2027-02-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,669 Indirect By ConocoPhillips Savings Plan
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $92.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges provided herein.
  2. Includes units acquired through routine dividend transactions that are exempt under rule 16a-11 and through a qualified plan that is exempt under rule 16b-3.